Skip to main content
BioPsychoSocial Medicine logoLink to BioPsychoSocial Medicine
. 2026 Apr 16;20:11. doi: 10.1186/s13030-026-00359-x

The impact of home-based telerehabilitation pranayama on sleep quality and wellbeing in mild to moderate obstructive sleep apnea syndrome. A randomized controlled trial

Zeynep Kaçar Akkoç 1,2, Rengin Demir 3,✉, Rüstem Mustafaoğlu 4, Ömer Önder Önder 5, Baha Naci 6, Ersan Atahan 7
PMCID: PMC13188614  PMID: 41992331

Abstract

Background

Obstructive sleep apnea syndrome (OSAS) is a common disorder that causes repeated airway obstruction, disrupted breathing, and fragmented sleep. This study aimed to investigate the effects of Pranayama on sleep quality, daytime sleepiness, quality of life, fatigue, depression, and anxiety in patients with OSAS.

Methods

This study was designed as an open-label, prospective, randomized controlled trial. OSAS patients meeting the inclusion criteria were randomly assigned to either an Intervention group or a Control group. Pranayama training was applied to the Intervention group for 8 weeks, 7 days a week, and 3 times a day for 15 min. In addition, a single 15-minute session, 3 days a week, was conducted online under the supervision of a physiotherapist. The control group did not receive any intervention. Primary outcome was sleep quality (Pittsburgh Sleep Quality Index, PSQI). Secondary outcomes included daytime sleepiness (Epworth Sleepiness Scale, ESS), Fatigue Severity Scale (FSS), Functional Outcomes of Sleep Questionnaire (FOSQ), Nottingham Health Profile (NHP), and Hospital Anxiety and Depression Scale (HADS). All outcome measures were assessed at baseline and reassessed after the 8-week intervention period.

Results

Thirty-eight OSAS patients meeting the inclusion criteria were randomly assigned to either an Intervention group (n = 19) or a Control group (n = 19). Four participants (two in each group) were lost to follow-up, leaving the data of 34 participants (17 per group) available for inclusion in the final analysis. In the intervention group, PSQI scores decreased from 9.12 ± 4.71 to 6.88 ± 4.45 (p < 0.001), whereas no improvement was observed in the control group. Regarding the primary outcome, the reduction in PSQI scores was significantly greater in the intervention group than in the control group (p < 0.001). The ESS scores also decreased significantly in the intervention group, from 9.41 ± 6.15 to 7.41 ± 6.18 (p = 0.006, with a significant between-group difference (p < 0.001). Fatigue severity decreased in the intervention group (FSS change: 0.53 ± 0.70; p = 0.006), with a significant between-group difference (p = 0.037). The FOSQ score improved markedly, with significant gains in FOSQ total score (− 0.38 ± 0.25 vs. 0.14 ± 0.22 in controls; p < 0.001) and in activity level and vigilance subdomains (both p < 0.001). The HADS-anxiety scores decreased by 1.94 ± 3.94 (p = 0.059) and depression scores by 3.06 ± 2.05 (p < 0.001) in the intervention group, with significant between-group differences for both anxiety (p = 0.008) and depression (p < 0.001).

Conclusion

Pranayama was an effective adjunct therapy for these OSAS patients, and incorporating it into treatment strategies may enhance patient outcomes.

Clinical trial registration number/date

NCT04632147/22.10.2020.

Keywords: Obstructive sleep apnea, Sleep quality, Quality of life, Daytime sleepiness, Fatigue, Depression

Introduction

Obstructive sleep apnea syndrome (OSAS) is a common sleep-related disorder characterized by recurrent events of upper airway obstruction, which lead to increased ventilatory efforts, intrathoracic pressure swings, intermittent hypoxia, and sleep fragmentation. The main manifestations are loud snoring, excessive daytime sleepiness, and witnessed apnea during sleep [1]. Hypoxia and hypercapnia during repeated apneic episodes result in predominant sympathetic nervous system activity, decreased vagal tone, and ultimately disrupted sympathovagal balance. Patients with OSAS demonstrate diminished heart rate variability due to autonomic dysfunction, which is closely related to the severity of OSAS [2–4].

The most effective treatment option for OSAS is nasal continuous positive airway pressure (CPAP), which causes significant improvements in the clinical symptoms [5]. However, most patients with OSAS cannot tolerate full-night CPAP therapy [6] and it has poor patient-compliance rates [7]. There is a need for new therapeutic approaches that have a high patient tolerance and that can be applied regardless of time and place.

Complementary therapies comprise diverse modalities such as music therapy, herbal remedies, reflexology, and yoga. Yoga exercises are a form of complementary therapy that effectively enhances physical, mental, and psychological well-being [8]. Yoga exercises are generally classified into three main categories: physical exercises (asana), breath control (pranayama), and meditation (dhyana) [9]. Pranayama, one of the practices of yoga intervention, basically focuses on the voluntary control of breathing, leading to a balanced autonomic nervous system through affecting vagal tone and heart rate variability [10, 11]. Pranayama has been shown to increase heart rate variability and to provide autonomic stability [12]. Excessive sympathetic nervous system activity leads to psychosomatic disorders, while slow, rhythmic breathing helps alleviate them [13]. No previous studies have investigated the effectiveness of pranayama in patients with OSAS. Thus, the current study was done to investigate the effects of pranayama on daytime sleepiness, sleep quality, quality of life, fatigue, depression, and anxiety levels in patients with OSAS.

Methods

Study design

This prospective, open-label, randomized controlled trial was carried out between May 2021 and August 2021 in the Chest Diseases Department of the Cerrahpaşa Faculty of Medicine Hospital at Istanbul University-Cerrahpasa, in accordance with the CONSORT 2025 guidelines [14]. All participants were informed about the objectives, procedures, and benefits of the study. Written informed consent was obtained from each patient. All procedures were performed in accordance with the Declaration of Helsinki. Ethical approval for the study was obtained from the Clinical Research Ethics Committee of Istanbul University-Cerrahpasa Faculty of Medicine (H-03) and registered at ClinicalTrials.gov with identification number NCT04632147.

Patients

Patients diagnosed with mild to moderate OSAS were recruited from the outpatient clinic. The OSAS diagnosis was established based on overnight polysomnography, in accordance with the American Academy of Sleep Medicine (AASM) criteria. Disease severity was classified using the apnea–hypopnea index (AHI), with mild OSAS defined as an AHI of 5–14 events/hour and moderate OSAS defined as an AHI of 15–29 events/hour [15]. The inclusion criteria were patients aged between 20 and 60 years who have an internet capable computer, tablet or smartphone, and no difficulty in reading, writing, and understanding Turkish. The exclusion criteria included using CPAP or a mandibular advancement device, additional respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma, requirement of hypnotic agents, using drugs such as beta-blockers that affect the sympathetic nervous system, previous maxillofacial surgery, craniofacial malformation, neurological and psychological disorders, malignancy, decompensated heart failure, diabetes, and severe cognitive impairments.

Randomization and allocation

Following an informative interview, participants who met the criteria gave written consent. Patients were randomly assigned to either an intervention group or a control group using a computer-based program to generate a list of random numbers [16]. A sequentially numbered series of envelopes was used for determining group allocation.

Interventions

The intervention group participated in an online Pranayama (yoga respiratory training) program delivered via WhatsApp video call, conducted in the home and/or workplace environment. On the initial day of the program, the techniques were demonstrated by the same physiotherapist. Participants engaged in a 15-minute training session, consisting of Ujjayi, Nadish Dhana, and Sukha pranayama, with each technique practiced for 5 min, performed three times daily over an 8-week period. Additionally, participants received online supervised training sessions three times per week. To assist with self-guided practice, a video demonstrating the techniques was sent via WhatsApp. A weekly follow-up chart was used, where participants recorded each session in which they engaged in the respiratory training program. This chart was reviewed online by the physiotherapist overseeing the intervention. The control group received no intervention.

Intervention group

To improve postural relaxation and parasympathetic activation, a preliminary process was performed prior to pranayama sessions. Patients were in sitting position with their feet in neutral position on the floor, fingers slightly flexed, head facing straight ahead, shoulders at the same level and slightly depressed, lips loose and teeth apart, throat loose, and t eyes slightly closed. They were requested to inhale slowly and deeply through the nose, and then to exhale through the nose again by relaxing the mimic muscles and shoulders, flexing the head and neck, and relaxing the whole body, then to maintain the relaxation position for 1 min. During the pranayama techniques, patients were instructed to carry out diaphragmatic breathing with an inhalation: exhalation ratio of 1:1 [17].

For the application of Ujjayi pranayama (psychic breath), the patient, in an upright seated position with the eyes closed, was asked to inhale and exhale through the nose several times at a normal respiratory rate. The patient mildly contracted the laryngeal muscles and inhaled through the nose until the air filled the thorax between the lungs and the throat with a hissing sound, “sa”. Then the patient exhaled completely by generating a snoring-like sound, “ha”, through mild contraction of the laryngeal muscles, and inhaled slowly and deeply through the nose again. This technique was applied for 5 min [18] (Fig. 1).

Fig. 1.

Fig. 1

Pranayama training program

To apply Nadish Dhana pranayama (alternate nostril breathing), the patient, seated in an upright position, was asked to press the right index and middle fingers lightly between the eyebrows while breathing normally through the nose for a few times. The patient was asked to close their eyes and to exhale completely through the nose. After the right nostril was closed by the right thumb, the patient inhaled deeply through the left nostril. Then the patient closed the left nostril with the right fourth finger and exhaled slowly through the right nostril, followed by deep inhalation through the right nostril. Finally, the patient exhaled slowly through the left nostril, keeping the right nostril closed with the right thumb. This practice, reflecting one cycle of Nadish Dhana pranayama, was performed for 5 min [18] (Fig. 1).

For the application of Sukha pranayama breathing exercises, the patient, sitting upright with the eyes closed, was asked to inhale and exhale regularly through the nostrils, each for 5 s: the technique was implemented for 5 min at a rate of 6 breathing cycles per minute [17] (Fig. 1).

The specific pranayama techniques included in the intervention were selected based on their documented physiological and autonomic effects. Slow and controlled pranayama practices have been shown to enhance parasympathetic activity and reduce sympathetic dominance, contributing to improved autonomic regulation, which is highly relevant in conditions characterized by autonomic imbalance, such as obstructive sleep apnea syndrome [8, 19]. Alternate nostril breathing has been demonstrated to significantly increase parasympathetic tone in healthy adults, supporting its inclusion as a targeted breathing exercise [20].

Control group

The control group received no intervention over an 8-week period.

Outcome measures

The primary outcome measure was sleep quality, while secondary outcome measures were daytime sleepiness, fatigue, depression, anxiety, and quality of life. Outcome measurements were carried out by WhatsApp video call method at baseline and 8 weeks. The questionnaires were sent to the patients through a WhatsApp message. In addition, survey questions were read verbally to the patients by researchers on a WhatsApp video call. Questionnaires were filled by the researcher according to the verbal answers of the patients.

Sleep quality

Sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI), a widely recognized tool for assessing various aspects of sleep. The PSQI consists of 19 self-rated items, which are categorized into seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction. The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality. A score of 5 or higher is typically used as a threshold to identify individuals with poor sleep quality. The PSQI has been validated in numerous populations and is commonly used in both clinical and research settings to assess sleep disturbances and their impact on overall health [21].

Daytime sleepiness

The Epworth Sleepiness Scale (ESS), which consists of 8 questions measuring the tendency to sleep during some activities throughout the day, was used for the daytime sleepiness assessment. Each question has a score ranging from 0 (I never nap) to 3 (I most likely doze off). A total score ≤ 5 is considered normal, while a score ≥ 16 indicates severe daytime sleepiness [22].

Fatigue

Fatigue level was evaluated with the Fatigue Severity Scale (FSS). The score range of each item is 1 (strongly disagree) to 7 (strongly agree). The scale score is obtained by calculating an average of 9 items on the scale. A scale score of less than 2.8 is defined as “no fatigue”, while a score more than 6.1 indicates the presence of “chronic fatigue” [23].

Quality of life

Generic quality of life was assessed using the Nottingham Health Profile (NHP). NHP includes subscales of pain, emotional reactions, sleep, social isolation, physical activity, and energy. Each subscore ranges from 0 to 100, and a higher score demonstrates worse quality of life. The sum of the six subscores forms a total score [24].

The Functional Outcomes of Sleep Questionnaire (FOSQ), consisting of the subscales general productivity, social outcome, activity level, and vigilance, was used for the assessment of disease-specific quality of life. The mean score of each subscale ranges from 0 to 4, with a lower score indicating a reduced quality of life. The total survey score is calculated as the sum of the subscale scores [25].

Anxiety and depression

Anxiety and depression levels were assessed using the Hospital Anxiety and Depression Scale (HADS), consisting of a total of 14 items. There are 7 items with the responses scored on a four-point likert scale for each parameter [26]. The cut-off values for the anxiety and depression levels in the Turkish version of HADS are 10 and 7, respectively [27].

Statistical analysis

Sample size was calculated using G*Power 3.1 statistical software (Universitat Dusseldorf, Germany) [28] according to the means and standard deviations (SD) for Pittsburgh Sleep Quality Index (PSQI) in a previous study that reported significant improvement for sleep quality, with an effect size of 1.06, in OSAS patients treated with Tai Chi and Qigong exercises [29]. A sample size of 17 patients was estimated to be required for each group to detect this improvement in PSQI with a power of 80%, an effect size of at least 1.00, and a confidence level of 95%. A dropout rate of 10% was considered, and it was determined that at least 19 participants were required in each group for the study.

Statistical analyses were conducted using the SPSS 25.0 statistical package (IBM SPSS Inc., Chicago, IL, US). Shapiro-Wilk test was used to analyze the normality of data distribution. Within-group differences were assessed through the Paired samples t-test. Between groups differences were assessed through the Independent samples t-test. Chi-squared test was used to compare proportions in non-independent groups. Baseline and after training data were reported as mean (SD) or frequency. A p-value less than 0.05 was accepted as statistically significant.

Results

Out of 40 patients with OSAS initially screened for eligibility, 38 met the inclusion criteria and were randomly assigned to one of the two groups. However, due to non-compliance (n = 2) or missing data (n = 2), four patients were excluded during the 8-week follow-up period. As a result, a total of 34 patients aged 28 to 60 years (10 female, 24 male; mean [SD] age: 46.21 [8.83] years) successfully completed the study, witht 17 patients in each group (Fig. 2). Baseline demographics and clinical characteristics of the patients are shown in Table 1. There were no statistically significant differences between groups (p > 0.05).

Fig. 2.

Fig. 2

CONSORT flow diagram

Table 1.

Baseline demographic data and clinical characteristics

Characteristics Intervention group
Mean ± SD or n (%)
Control group
Mean ± SD or n (%)
p value
Age (years) 44.71 (9.19) 47.71 (8.46) 0.330
BMI (kg/m²) 30.19 (4.39) 31.22 (6.67) 0.600
Female 5 (29.4%) 5 (29.4%) 1.000
Male 12 (70.6%) 12 (70.6%)
AHI-mild/moderate 9 (52.9) /8 (47.1) 9 (52.9) /8 (47.1) 0.563
PSQI 9.12 (4.71) 8.76 (3.38) 0.804
ESS 9.41 (6.15) 11.71 (4.19) 0.214
HADS
Anxiety 7.88 (5.05) 7.00 (3.53) 0.559
Depression 6.18 (4.53) 7.59 (4.85) 0.387
Total 14.05 (8.95) 14.58 (7.49) 0.853
NHP
Pain 21.43 (30.07) 21.39 (17.60) 0.462
Emotional Reactions 33.09 (33.73) 35.73 (30.24) 0.658
Sleep 43.93 (28.60) 49.28 (28.10) 0.496
Social Isolation 21.57 (31.84) 33.10 (31.46) 0.274
Physical Activity 22.54 (26.64) 20.23 (16.11) 0.812
Energy 48.98 (41.90) 52.04 (39.74) 0.786
Total 191.50 (162.90) 211.70 (104.30) 0.669
FOSQ
General Productivity 3.37 (0.75) 3.30 (0.55) 0.413
Social Outcome 3.37 (0.84) 3.47 (0.81) 0.657
Activity Level 2.87 (0.67) 2.88 (0.64) 0.952
Vigilance 2.94 (0.83) 2.76 (0.80) 0.474
Total 3.10 (0.64) 3.02 (0.56) 0.610
FSS 3.40 (2.06) 4.27 (1.52) 0.173

Data are reported as mean (standard deviation) or n (%); statistical significance at p < 0.05. The p-values are from the Independent Samples t test

AHI: Apnea-Hypopnea Index; BMI: body mass index; ESS: Epworth Sleepiness Scale; FOSQ: Functional Outcomes of Sleep Questionnaire; FSS: Fatigue Severity Scale; HADS: Hospital Anxiety Depression Scale; NHP: Nottingham Health Profile; PSQI: Pittsburgh Sleep Quality Index; SD: standard deviation

Primary outcome

Sleep quality

The intervention group demonstrated a significant improvement in sleep quality, as evidenced by a substantial decrease in the PSQI scores from baseline to post-training. In contrast, the control group showed a worsening trend in PSQI scores during the same period. Between-group comparisons confirmed that the improvement in the intervention group was statistically superior to the control group (p < 0.001; Table 2).

Table 2.

Comparisons of sleep quality, daytime sleepiness, disease-specific quality of life, and fatigue both within and between groups

Outcome variable Baseline
Mean (SD)
After training
Mean (SD)
Within-group change
mean (SD)
Within-group
p valuea
Between-group p valueb
PSQI
 Intervention group 9.12 (4.71) 6.88 (4.45) 2.23 (1.92) < 0.001 < 0.001
 Control group 8.76 (3.38) 9.71 (3.75) -0.94 (1.71) 0.040
ESS
 Intervention group 9.41 (6.15) 7.41 (6.18) 2.00 (2.29) 0.006 < 0.001
 Control group 11.71 (4.19) 12.65 (4.10) -0.94 (1.34) 0.014
FOSQ
General Productivity
 Intervention group 3.37 (0.75) 3.60 (0.59) -022 (0.37) 0.023 0.011
 Control group 3.30 (0.55) 3.19 (0.53) 0.10 (0.27) 0.005
Social Outcome
 Intervention group 3.37 (0.84) 3.65 (0.78) -0.28 (0.54) 0.083 0.025
 Control group 3.47 (0.81) 3.35 (0.87) 0.11 (0.33) 0.157
Activity Level
 Intervention group 2.87 (0.67) 3.30 (0.57) -0.43 (0.34) < 0.001 < 0.001
 Control group 2.88 (0.64) 2.73 (0.61) 0.15 (0.31) 0.060
Vigilance
 Intervention group 2.94 (0.83) 3.49 (0.55) -0.54 (0.39) < 0.001 < 0.001
 Control group 2.76 (0.80) 2.51 (0.70) 0.24 (0.43) 0.019
Total
 Intervention group 3.10 (0.64) 3.49 (0.54) -0.38 (0.25) 0.001 < 0.001
 Control group 3.02 (0.56) 2.88 (0.53) 0.14 (0.22) 0.006
FSS
 Intervention group 3.40 (2.06) 2.86 (2.10) 0.53 (0.70) 0.006 0.037
 Control group 4.27 (1.52) 4.19 (1.62) 0.08 (0.50) 0.529

Data are reported as mean (standard deviation) or n (%); statistical significance at p < 0.05. The p-values are from Paired Samples t test (a) and Independent Samples t test (b)

ESS: Epworth Sleepiness Scale; FOSQ: Functional Outcomes of Sleep Questionnaire; FSS: Fatigue Severity Scale; PSQI: Pittsburgh Sleep Quality Index; SD: standard deviation

Secondary outcomes

Daytime sleepiness and fatigue

The ESS scores declined significantly in the intervention group (p = 0.006), suggesting reduced daytime sleepiness. Conversely, the control group experienced a worsening of ESS scores (p = 0.014), with a significant between-group difference (p < 0.001) (Table 2). Similarly, fatigue severity improved significantly in the intervention group (p = 0.006), while no significant change was observed in the control group (p = 0.529). The between-group analysis also revealed a significant difference in favor of the intervention group (p = 0.037) (Table 2).

Quality of life

Regarding FOSQ, the intervention group showed significant improvements in general productivity (p = 0.023), activity level (p < 0.001), vigilance (p < 0.001), and total scores (p = 0.001). Between-group comparisons demonstrated significant differences for all these subdomains (p < 0.05), indicating superior outcomes in the intervention group. However, social outcome scores did not significantly change within the intervention group (p = 0.083), though a significant difference was noted in the between-group comparison (p = 0.025) (Table 2).

In the NHP, the intervention group showed significant improvements in emotional reactions (p < 0.001), sleep (p = 0.005), social isolation (p = 0.026), energy levels (p = 0.025), and total score (p < 0.001). In contrast, the control group exhibited a deterioration in these domains, with significant worsening in social isolation (p = 0.017), energy (p = 0.038), and total NHP score (p = 0.004). Between-group comparisons revealed significant differences in emotional reactions, sleep, social isolation, energy, and total NHP scores (p < 0.05) (Table 3).

Table 3.

Comparisons of generic quality of life, anxiety, and depression both within and between groups

Outcome variable Baseline
Mean (SD)
After training
Mean (SD)
Within-group change
mean (SD)
Within-group
p valuea
Between-group p valueb
NHP
Pain
 Intervention group 21.43 (30.07) 16.89 (29.43) 4.53 (9.92) 0.123 0.067
 Control group 21.39 (17.60) 21.84 (18.17) 0.45 (7.15) 0.462
Emotional Reactions
 Intervention group 33.09 (33.73) 12.06 (21.50) 21.02 (17.88) 0.001 < 0.001
 Control group 35.73 (30.24) 40.90 (27.60) -5.17 (18.00) 0.213
Sleep
 Intervention group 43.93 (28.60) 28.95 (30.97) 14.97 (14.83) 0.005 0,001
 Control group 49.28 (28.10) 53.76 (29.29) -4.48 (12.78) 0.144
Social Isolation
 Intervention group 21.57 (31.84) 12.80 (22.96) 8.76 (13.44) 0.026 0.002
 Control group 33.10 (31.46) 42.20 (33.71) -9.09 (12.52) 0.017
Physical Activity
 Intervention group 22.54 (26.64) 17.36 (25.65) 5.17 (9.70) 0.043 0.099
 Control group 20.23 (16.11) 20.77 (16.70) -0.54 (2.25) 0.317
Energy
 Intervention group 48.98 (41.90) 26.21 (33.53) 22.77 (36.39) 0.025 0.001
 Control group 52.04 (39.74) 60.61 (35.78) -8.56 (14.11) 0.038
Total
 Intervention group 191.50 (162.90) 114.30 (137.60) 77.20 (57.00) 0.001 < 0.001
 Control group 211.70 (104.30) 240.10 (102.70) 28.30 (36.70) 0.004
HADS
Anxiety
 Intervention group 7.88 (5.05) 5.94 (4.84) 1,94 (3,94) 0.059 0.008
 Control group 7.00 (3.53) 8.12 (3.26) -1,12 (2,12) 0.053
Depression
 Intervention group 6.18 (4.53) 3.12 (3.35) 3.06 (2.05) < 0.001 < 0.001
 Control group 7.59 (4.85) 9.29 (4.57) -1.70 (3.16) 0.024
Total
 Intervention group 14.05 (8.95) 9.05 (7.39) 5.00 (4.50) < 0.001 < 0.001
 Control group 14.58 (7.49) 17.41 (6.82) -2.82 (4.85) 0.012

Data are reported as mean (standard deviation) or n (%); statistical significance at p < 0.05. The p-values are from Paired Samples t test (a) and Independent Samples t test (b)

HADS: Hospital Anxiety Depression Scale; NHP: Nottingham Health Profile; SD: standard deviation

Anxiety and depression

The intervention group demonstrated a significant reduction in depression scores (p < 0.001) and total HADS scores (p < 0.001), while the control group experienced a worsening of both parameters (p = 0.024 and p = 0.012, respectively). Although anxiety scores decreased within the intervention group, the change was not statistically significant (p = 0.059), but the between-group comparison showed a significant difference (p = 0.008) (Table 3).

Adverse events

No adverse events or serious complications were reported by the participants during the intervention period, and no safety concerns necessitating discontinuation of the intervention were observed.

Discussion

This randomized controlled study is the first to examine the effects of pranayama (yoga respiratory) training applied alone without an additional therapy method on daytime sleepiness, disease-specific quality of life, general quality of life, sleep quality, fatigue, depression and anxiety parameters in OSAS patients. The pranayama group showed significantly greater improvements than the control group in sleep quality, daytime sleepiness, disease-specific and generic quality of life, fatigue severity, depression, and anxiety-depression scores. The potential mechanisms underlying these improvements may be explained by the effects of pranayama on respiratory control and autonomic regulation. Slow, controlled breathing has been shown to increase vagal tone and suppress sympathetic activity, leading to reductions in physiological arousal and stress-related hyperactivation, which are commonly observed in patients with OSAS [8, 9].

Another study reported a significant decrease in PSQI and ESS scores in OSAS patients who participated in a 3-month yoga program that included yoga respiratory training [30], but it was not a controlled study. In another study, OSAS patients were randomized into two groups, an oropharyngeal exercises and pranayama group and a sham therapy group. No significant change was observed in the total PSQI or ESS scores of the sham treatment group, while there was a significant decrease in the total PSQI and ESS scores of the oropharyngeal exercises and pranayama group [31]. In parallel with the results of these studies, there was a significant decrease in the PSQI and ESS scores of the pranayama group in our study, while there was no significant change in the PSQI score and a significant increase in the ESS score of the control group. Our study showed that 8 weeks of pranayama practice was effective in improving sleep quality and daytime sleepiness in OSAS patients. These findings are consistent with previous studies indicating that controlled breathing techniques may enhance sleep quality by modulating autonomic nervous system activity and promoting parasympathetic dominance, thereby reducing sleep fragmentation and improving sleep continuity [9, 32].

Anxiety reduction and improved mental-health scores have been documented after structured breathing interventions in randomized or pilot trials [33]. There are limited studies examining the effect of pranayama alone on depression and anxiety. It has been reported that pranayama applied in addition to conventional medicine in young individuals with bronchial asthma is superior to conventional medicine in improving depression and anxiety alone [34]. In a randomized controlled study, supervised sukha pranayama was performed for 5 min in an experimental group of coronary angiography candidates. A control group received only standard preangiography care. The anxiety levels of the patients in both groups were measured before the intervention, half an hour after the intervention, and one hour after the intervention. The results showed a decrease in the anxiety level of both groups, but the decrease in the control group was not statistically significant [35]. In a study conducted by Khalsa et al., people with general anxiety disorder were included in a program in which cognitive behavioral therapy and yoga were applied together. A yoga program including breathing exercises along with cognitive behavioral therapy was applied to the individuals for 6 weeks. The study found significant improvements in anxiety and depression in individuals with general anxiety disorder [36]. In our study, at the end of 8 weeks, we detected a significant decrease in HAD depression and total score in the pranayama group, and a significant increase in the control group. We found a non-significant decrease in the HAD anxiety score of the Pranayama group and an insignificant increase in the HAD anxiety score of the control group. The difference in HAD depression score, anxiety score, and total score changes between the groups was statistically significant. The results of our study showed that paranayama is an effective method for reducing anxiety and depression in patients with OSAS.

Improvements in general well-being and quality-of-life-type measures have been reported in breathing-intervention studies [33, 37]. In a randomized controlled study in which elderly women with breast cancer participated, it was found that a yoga program applied in addition to an exercise intervention decreased all subscores of NHP and the total score; It has been reported that the decrease in emotional reactions, social isolation, sleep and physical activity sub-scores is superior to exercise alone [38]. In our study, all sub-parameter scores and total scores were significantly reduced in the pranayama group, except for the NHP pain sub-parameter. There were significant increases in social isolation, energy sub-parameter scores, and total NHP scores in the control group. In addition, decreases in emotional reactions, sleep, social isolation, energy sub-parameter scores, and total scores were significantly superior to the control group in the pranayama group. In our study, we found a significant improvement in the general quality of life in the pranayama group, in line with the existing literature.

Disease-specific quality of life in OSAS populations after pranayama was not comprehensively reported in the surveyed trials, limiting cross-study comparison for OSAS-specific quality of life. However, in a study examining the effect of exercise on OSAS, 20 individuals with OSAS were randomized into control and exercise groups. While no treatment was applied to the control group, an exercise program consisting of 12-week breathing exercises and aerobic exercises was applied to the exercise group for 1.5 h a day, 3 days a week. At the end of 12 weeks, no significant change was observed in FOSQ, tr scores in the control group, while it was reported that there was a significant improvement in FOSQ, tr activity level in the exercise group, but this improvement did not differ significantly compared to the control group [39]. In our study, significant improvements were found in the disease-specific quality of life of the pranayama group at the end of 8 weeks. Changes in FOSQ, tr sub parameter scores and total score were significantly different between the two groups.

Fatigue symptoms may occur because of nocturnal hypoxemia seen in OSAS [40]. It has been reported that the level of fatigue decreased significantly in patients with OSAS who applied online breathing techniques including diaphragmatic breathing and pursed lip breathing daily [1]. In our study, in parallel with the literature, a statistically significant decrease was observed in the FSS score of the pranayama group at the end of 8 weeks. There was no significant change in the FSS score in the control group. In addition, the change in FSS score was significantly different in the pranayama group from the control group. We found that yoga respiratory training resulted in a reduction in fatigue in patients with OSAS.

Existing studies suggest that pranayama may be a feasible adjunctive approach to standard treatments in patients with OSAS. Interventional studies targeting sleep-disordered breathing have reported improvements in key respiratory parameters, such as the apnea–hypopnea index (AHI), along with symptomatic benefits. These findings indicate that pranayama may hold potential as a complementary therapeutic option in selected patients with OSAS [41]. In this context, the improvements observed in sleep quality, daytime sleepiness, and psychological symptoms in our study are consistent with these previously reported clinical benefits, further supporting the notion that pranayama may exert positive effects not only on physiological outcomes but also on functional and psychosocial domains.

Limitations

In our study AHI was not measured after pranayama training. Examining the AHI changes of the patients compared to the pre-study could more objectively reveal the effect of pranayama training on OSAS. Second, blindness could not be achieved because the assessments and the pranayama training program were administered by the same physiotherapist.

Conclusion

The results of this study showed that pranayamic techniques have favorable effects on the daytime sleepiness, sleep quality, generic and disease-specific quality of life, fatigue, depression, and anxiety levels in OSAS patients. More randomized controlled trials are needed to confirm the efficacy of pranayama in OSAS.

Acknowledgements

Thanks to Caroline Walker for editing and revising the English format of this article.

Abbreviations

OSAS

Obstructive sleep apnea syndrome

CPAP

Continuous positive airway pressure

COPD

Chronic obstructive pulmonary disease

PSQI

Pittsburgh Sleep Quality Index

NHP

Nottingham Health Profile

FOSQ

Functional Outcomes of Sleep Questionnaire

ESS

Epworth Sleepness Scale

FSS

Fatigue Severity Scale

HADS

Hospital Anxiety and Depression Scale

Author contributions

Z.K.A. was responsible for the study design, data collection, data analysis, and manuscript writing. R.D. contributed to data analysis and manuscript editing. R.M. was involved in manuscript writing. Ö.Ö.Ö. contributed to the development of the methodological framework. B.N. contributed to the editing of the manuscript. E.A. contributed to data collection.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or non-profit sectors.

Data availability

Data set will be provided upon reasonable request.

Declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Clinical Research Ethics Committee of Istanbul University-Cerrahpasa Faculty of Medicine (Approval No: H-03) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Prior presentation

No representation of this material has been made available to anyone, anywhere.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15(4):376–81. 10.1093/sleep/15.4.376.  [DOI] [PubMed] [Google Scholar]
  • 2.Kheirandish-Gozal L, Bhattacharjee R, Gozal D. Autonomic alterations and endothelial dysfunction in pediatric obstructive sleep apnea. Sleep Med. 2010;11(7):714–20. 10.1016/j.sleep.2009.12.013. [DOI] [PubMed] [Google Scholar]
  • 3.Sequeira VCC, Bandeira PM, Azevedo JCM. Heart rate variability in adults with obstructive sleep apnea: a systematic review. Sleep Sci. 2019;12(3). 10.5935/1984-0063.20190082. [DOI] [PMC free article] [PubMed]
  • 4.Park DH, Shin CJ, Hong SC, et al. Correlation between severity of obstructive sleep apnea and heart rate variability indices. J Korean Med Sci. 2008;23(2):226–32. 10.3346/jkms.2008.23.2.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chang HP, Chen YF, Du JK. Obstructive sleep apnea treatment in adults. Kaohsiung J Med Sci. 2020;36(1):7–12. 10.1002/kjm2.12130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Borel JC, Pelletier J, Taleux N, Briault A, Arnol N, Tamisier R, Pepin JL. Long-term adherence to continuous positive airway pressure in mild obstructive sleep apnea. BMC Pulm Med. 2023;23(1):312. 10.1186/s12890-023-02612-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004;169(3):361–6. 10.1164/rccm.200306-752OC. [DOI] [PubMed] [Google Scholar]
  • 8.Cramer H, Hall H, Leach M, Lauche R. Yoga-based exercise improves health-related quality of life and mental well-being in older people: A systematic review of randomized controlled trials. Age Ageing. 2018;47(4):537–43. 10.1093/ageing/afy071. [DOI] [PubMed] [Google Scholar]
  • 9.Feuerstein G. The Yoga Tradition: Its History, Literature, Philosophy and Practice. California: SCB Distributors; 2012. [Google Scholar]
  • 10.Jerath R, Edry JW, Barnes VA, Jerath V. Physiology of long pranayamic breathing: Neural respiratory elements may explain how slow deep breathing shifts autonomic balance. Med Hypotheses. 2006;67(3):566–71. 10.1016/j.mehy.2006.02.042. [DOI] [PubMed] [Google Scholar]
  • 11.Brown RP, Gerbarg PL. Sudarshan Kriya yogic breathing in the treatment of stress, anxiety, and depression: Part I — neurophysiologic model. J Altern Complement Med. 2005;11(1):189–201. 10.1089/acm.2005.11.189. [DOI] [PubMed] [Google Scholar]
  • 12.Bhimani NT, Kulkarni NB, Kowale A, Salvi S. Effect of pranayama on stress and cardiovascular autonomic tone and reactivity. Nat J Integ Res Med. 2011;2:48–54. [PubMed] [Google Scholar]
  • 13.Streeter CC, Gerbarg PL, Saper RB, et al. Effects of yoga on autonomic function, GABA, and allostasis in epilepsy, depression and PTSD. Med Hypotheses. 2012;78(5):571–9. 10.1016/j.mehy.2012.01.021. [DOI] [PubMed] [Google Scholar]
  • 14.Hopewell S, Chan AW, Collins GS, Hróbjartsson A, Moher D, Schulz KF, Tunn R, Aggarwal R, Berkwits M, Berlin JA, Bhandari NJ, Butcher NJ, Campbell MK, Chidebe RCW, Elbourne D, Farmer A, Fergusson DL, Golub RM, Goodman SN, White IR. CONSORT 2025 statement: Updated guideline for reporting randomised trials. JAMA. 2025. 10.1001/jama.2025.4347.40294593 [Google Scholar]
  • 15.Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: An American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479–504. 10.5664/jcsm.6506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Research Randomizer [Internet]. Randomizer.org; cited 2021 May 1. Available from: https://www.randomizer.org/.
  • 17.Önder Ö. Nefesten Solunuma. İstanbul: Kuraldışı Yayıncılık Eğitim Danışmanlık Ltd Şti; 2019. [Google Scholar]
  • 18.Saraswati SS. Asana Pranayama Mudra Bandha. 3rd rev ed. Bihar: Bihar Yoga Bharati; 2002.
  • 19.Pal GK, Velkumary S, Madanmohan. Effect of short-term practice of breathing exercises on autonomic functions in normal human volunteers. Indian J Med Res. 2004;120(2):115–21. [PubMed] [Google Scholar]
  • 20.Sinha AN, Deepak D, Gusain VS. Assessment of the effects of pranayama/alternate nostril breathing on the parasympathetic nervous system in young adults. J Clin Diagn Res. 2013;7(5):821–3. 10.7860/JCDR/2013/4750.2948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric research. Psychiatry Res. 1989;28(2):193–213. 10.1016/0165-1781(89)90047-4. [DOI] [PubMed] [Google Scholar]
  • 22.Krupp LB, Alvarez LA, LaRocca NG, et al. Fatigue in multiple sclerosis. Arch Neurol. 1988;45(4):435–7. 10.1001/archneur.1988.00520280085020. [DOI] [PubMed] [Google Scholar]
  • 23.Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–70. 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  • 24.Hunt SM, McKenna SP, McEwen J, et al. Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A. 1981;15(3 Pt 1):221–9. 10.1016/0271-7123(81)90005-5. [DOI] [PubMed] [Google Scholar]
  • 25.Izci B, Firat H, Ardiç S, et al. Adaptation of functional outcomes of sleep questionnaire to Turkish. Tuberk Toraks. 2004;52(3):224 – 30. Available from: https://pubmed.ncbi.nlm.nih.gov/15351934. [PubMed]
  • 26.Aydemir Ö. Hastane Anksiyete ve Depresyon Ölçeği Türkçe formunun geçerlilik-güvenilirliği. Turk Psikiyatri Derg. 1997;8:187–280. [Google Scholar]
  • 27.Kumar V, Malhotra V, Kumar S. Standardised yoga protocols as physiotherapy recommendation in sleep apnea. Indian J Otolaryngol Head Neck Surg. 2019;71(S1):558–65. 10.1007/s12070-018-1405-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program. Behav Res Methods. 2007;39(2):175–91. 10.3758/BF03193146. [DOI] [PubMed] [Google Scholar]
  • 29.Yilmaz Gokmen G, Akkoyunlu ME, Kilic L, Algun C. Effect of tai chi and qigong training in obstructive sleep apnea: A randomized controlled study. J Altern Complement Med. 2019;25(3):317–25. 10.1089/acm.2018.0197. [DOI] [PubMed] [Google Scholar]
  • 30.Kaur A, Mitra M. Effect of oropharyngeal exercises and pranayama in moderate OSA. Eur Respir Soc. 2019. 10.1183/13993003.congress-2019.PA577. [Google Scholar]
  • 31.Sangeethalaxmi MJ, Hankey A. Yoga breathing and relaxation in asthma: randomized controlled trial. J Ayurveda Integr Med. 2023;14(1):100546. 10.1016/j.jaim.2022.100546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sengupta P. Health impacts of yoga and pranayama: A state-of-the-art review. Int J Prev Med. 2012;3(7):444–58. [PMC free article] [PubMed] [Google Scholar]
  • 33.Ganesan V, Fowler L, Bajaj S, Qu H, Singh P. Sudarshan kriya yoga (SKY) breath meditation on heart rate variability, sleep and mental health in healthy individuals: A pilot and feasibility randomized controlled trial. medRxiv. 2025. 10.1101/2025.01.04.25319992.40950448 [Google Scholar]
  • 34.Mobini Bidgoli M, Taghadosi M, Gilasi H, et al. Effect of sukha pranayama on anxiety in coronary angiography: randomized controlled trial. J Cardiovasc Thorac Res. 2016;8(4):170–5. 10.15171/jcvtr.2016.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Khalsa MK, Greiner-Ferris JM, Hofmann SG, et al. Yoga-enhanced cognitive behavioral therapy for anxiety: pilot trial. Clin Psychol Psychother. 2015;22(4):364–71. 10.1002/cpp.1902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Yagli NV, Ulger O. Effects of yoga on quality of life and depression in elderly breast cancer patients. Complement Ther Clin Pract. 2015;21(1):7–10. 10.1016/j.ctcp.2015.01.002. [DOI] [PubMed] [Google Scholar]
  • 37.Castro PB, Kowdley HG, Joyner RL, Kowdley G. Sudarshan kriya yoga and its effects on sleep: a systematic review of a breathing technique for sleep improvement. J Appl Conscious Stud. 10.4103/jacs.jacs_161_23.
  • 38.Sengul YS, Ozalevli S, Oztura I, et al. Effect of exercise in obstructive sleep apnea: randomized trial. Sleep Breath. 2011;15(1):49–56. 10.1007/s11325-009-0311-1. [DOI] [PubMed] [Google Scholar]
  • 39.Vanuxem D, Badier M, Guillot C, et al. Impairment of muscle energy metabolism in sleep apnea. Respir Med. 1997;91(9):551–7. 10.1016/S0954-6111(97)90089-5. [DOI] [PubMed] [Google Scholar]
  • 40.Serçe S, Ovayolu Ö, Bayram N, et al. Effect of breathing exercise on daytime sleepiness and fatigue in OSA. J Breath Res. 2022;16(4):046006. 10.1088/1752-7163/ac894d. [DOI] [PubMed] [Google Scholar]
  • 41.Yelkur P, Manivel R, Mohammed S, Rachakonda S, Umapathy N, Akash VC. Impact of nadi shuddhi pranayama on apnea hypopnea index, respiratory distress index, and oxygen desaturation index among adolescents with sleep apnea syndrome. Cureus. 2024;16(7):e65848. 10.7759/cureus.65848. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data set will be provided upon reasonable request.


Articles from BioPsychoSocial Medicine are provided here courtesy of BMC

RESOURCES